SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012324
Filing Date
2020-11-03
Accepted
2020-11-03 09:31:55
Documents
77
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ampe-20200930x10q.htm   iXBRL 10-Q 1731907
2 EX-31.1 ampe-20200930xex31d1.htm EX-31.1 15548
3 EX-31.2 ampe-20200930xex31d2.htm EX-31.2 15536
4 EX-32.1 ampe-20200930xex32d1.htm EX-32.1 8079
5 GRAPHIC ampe-20200930x10q002.jpg GRAPHIC 2119
6 GRAPHIC ampe-20200930x10q003.jpg GRAPHIC 34709
  Complete submission text file 0001558370-20-012324.txt   7682671

Data Files

Seq Description Document Type Size
7 EX-101.SCH ampe-20200930.xsd EX-101.SCH 56440
8 EX-101.CAL ampe-20200930_cal.xml EX-101.CAL 47496
9 EX-101.DEF ampe-20200930_def.xml EX-101.DEF 180046
10 EX-101.LAB ampe-20200930_lab.xml EX-101.LAB 390653
11 EX-101.PRE ampe-20200930_pre.xml EX-101.PRE 345358
12 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20200930x10q_htm.xml XML 1644651
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 201282110
SIC: 2834 Pharmaceutical Preparations